Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018;33(5):10.4102/sajid.v33i5.138.
doi: 10.4102/sajid.v33i5.138. Epub 2018 Aug 20.

Uptake and Cost of Influenza Vaccines in a Private Health Insured South African Population

Affiliations
Free PMC article

Uptake and Cost of Influenza Vaccines in a Private Health Insured South African Population

Geetesh Solanki et al. S Afr J Infect Dis. .
Free PMC article

Abstract

Background: Influenza vaccination is regarded as the most effective form of prevention and is particularly recommended for individuals at increased risk of developing severe influenza. Data on uptake (coverage) and costs in South Africa are limited.

Methods: This study examined influenza vaccination uptake amongst South African private health insurance scheme members. All claims received for services rendered in 2015 were collated at an individual level and the claims related to the provision of influenza vaccines were analysed.

Results: Of the almost 520 000 members, overall 5.0% (95% CI 4.9%; 5.1%) received the influenza vaccine in 2015. Priority risk groups such as pregnant women, older adults and those with a medical condition were significantly more likely to be vaccinated, as were members belonging to insurance schemes that offered a specific influenza vaccine benefit. The average cost of providing the vaccination was R350.

Conclusions: Influenza vaccination coverage was low in this privately insured population. There were more members vaccinated in the priority risk groups. There is an urgent need to implement strategies to increase this coverage in privately insured South Africans.

Keywords: South Africa; influenza; private health insurance; uptake; vaccination.

Conflict of interest statement

Disclosure statement – No potential conflict of interest was reported by the authors.

Similar articles

See all similar articles

References

    1. Gessner BD, Shindo N, Briand S. Seasonal influenza epidemiology in sub-Saharan Africa: a systematic review. Lancet Infect Dis. 2011;11 (3):223–35. - PubMed
    1. Rotrosen ET, Neuzil KM. Influenza: a global perspective. Pediatr Clin North Am. 2017;64(4):911–36. - PubMed
    1. World Health Organization. Influenza: vaccine use Geneva: Switzerland: World Health Organization; 2017. [Available from: http://who.int/influenza/vaccines/use/en/.
    1. National Department of Health. National influenza policy and strategic plan: 2017 to 2021. Pretoria: South Africa.
    1. Katz MA, Schoub BD, Heraud JM, et al. Influenza in Africa: uncovering the epidemiology of a long-overlooked disease. J Infect Dis. 2012;206 (Suppl 1):S1–4. - PubMed

LinkOut - more resources

Feedback